| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/2004 | DE19906975B4 Arzneiform zur Behandlung von Alzheimer'scher Demenz Dosage form for the treatment of Alzheimer's dementia |
| 04/15/2004 | DE10296335T5 Pharmazeutische Formulierungen Pharmaceutical formulations |
| 04/15/2004 | DE10246377A1 Production of plaster useful for prolonged release of active agent, especially essential oil, comprising coating one side of absorbent carrier with adhesive then charging opposite side with active agent |
| 04/15/2004 | DE10246374A1 New 4-(2-alkylamino-1-hydroxyethyl)-3-alkoxy-benzene-1,2-diol derivatives, are beta-mimetics having a long duration of action, useful e.g. for treating asthma, chronic obstructive pulmonary disease or arrhythmia |
| 04/15/2004 | DE10246357A1 Medicaments for prolonging both REM and non-REM sleep, containing 5-HT-2 receptor antagonists, preferably N-(indolyl-carbonyl)-piperazine derivatives |
| 04/15/2004 | DE10246329A1 New receptor protein, useful for detecting specific-binding aldehydes or their antagonists that can be used as contraceptives and conception-promoting agents |
| 04/15/2004 | DE10244907A1 Orally administered dietetic food, nutritional supplement or medicament, especially for improving sporting performance, comprising mixture of L-carnitine and eicosapentaenoic and docosahexaenoic acids |
| 04/15/2004 | DE10243233A1 Verwendung von Substanzen zum Schutz der Haut Use of substances for protecting the skin |
| 04/15/2004 | CA2509526A1 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 04/15/2004 | CA2504015A1 Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma |
| 04/15/2004 | CA2501981A1 Nitroxide radioprotector formulations and methods of use |
| 04/15/2004 | CA2501663A1 Stilbene derivatives having an immune-modulating activity |
| 04/15/2004 | CA2500969A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | CA2500869A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | CA2500822A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/15/2004 | CA2500729A1 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | CA2500723A1 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 04/15/2004 | CA2500716A1 Compositions comprising highly purified amphotericin b |
| 04/15/2004 | CA2500714A1 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | CA2500664A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 04/15/2004 | CA2500663A1 Enteric composition for the manufacture of soft capsule wall |
| 04/15/2004 | CA2500662A1 Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders |
| 04/15/2004 | CA2500661A1 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 04/15/2004 | CA2500527A1 Remedies |
| 04/15/2004 | CA2500328A1 Use of cyclic depsipeptide as a chemotherapeutic agent against cancer |
| 04/15/2004 | CA2500259A1 Potent inhibitor of hcv serine protease |
| 04/15/2004 | CA2500065A1 Sustained release porous microparticles for inhalation |
| 04/15/2004 | CA2500062A1 Fast-release administration form with slightly soluble active ingredient |
| 04/15/2004 | CA2500056A1 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 04/15/2004 | CA2499483A1 Novel chemokine-like polypeptides |
| 04/15/2004 | CA2498555A1 Combination chemotherapy with dehydroequol and selected chemotherapeutic agents |
| 04/15/2004 | CA2498337A1 Hydroxyphenylundecane derivatives, a process for their production and their use |
| 04/15/2004 | CA2498186A1 Cyclic nitromethyl acetic acid derivatives |
| 04/15/2004 | CA2498026A1 Compositions for treatment of prostate and other cancers |
| 04/15/2004 | CA2496565A1 Non-nucleoside reverse transcriptase inhibitors |
| 04/15/2004 | CA2495698A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/15/2004 | CA2495055A1 17.beta.-estradiol/levonorgestrel transderm patch for hormone replacement therapy |
| 04/14/2004 | EP1408119A1 Method of screening abc protein promoter/inhibitor |
| 04/14/2004 | EP1408110A2 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 04/14/2004 | EP1408066A1 Block copolymer reduced in impurity content; polymeric carrier; pharmaceutical preparations in polymeric form and process for the preparation of the same |
| 04/14/2004 | EP1408045A1 Novel galactosylceramide analogs and beta-glucocerebrosidase activators,external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 04/14/2004 | EP1408039A2 Mixed paraxetine propan-2-ol solvates |
| 04/14/2004 | EP1408037A1 Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect |
| 04/14/2004 | EP1408034A1 Use of Quinoline derivatives as antibacterial agents |
| 04/14/2004 | EP1408032A2 Coupling product between tryptamine and an alpha-amino acid and its use in the field of neuro-cosmetics |
| 04/14/2004 | EP1408031A1 Pyrolidine derivatives useful in treatment of hepatitis C virus infection |
| 04/14/2004 | EP1408030A1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 04/14/2004 | EP1408028A1 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 04/14/2004 | EP1407786A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 04/14/2004 | EP1407785A1 Medicinal compositions |
| 04/14/2004 | EP1407784A1 Antitumor agents |
| 04/14/2004 | EP1407779A1 Use of ghrelin for treating low body weight and body fat in gastrectomized individuals |
| 04/14/2004 | EP1407776A1 A pharmaceutical colloidal preparation comprising hyaluronic acid biopolymers useful in the treatment of respiratory diseases |
| 04/14/2004 | EP1407775A1 Medical preparation for parenteral injection |
| 04/14/2004 | EP1407774A1 2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds |
| 04/14/2004 | EP1407772A1 Pharmaceutical composition comprising porous spherical carbonaceous substance and its use for the treatment of renal and liver diseases |
| 04/14/2004 | EP1407771A1 Sophoridine and use thereof as an analgesic |
| 04/14/2004 | EP1407770A1 Tgf-beta superfamily production/secretion promoter |
| 04/14/2004 | EP1407768A2 The potassium channel opener retigabine for the treatment of diseases |
| 04/14/2004 | EP1407767A1 Pparg agonistic medicinal compositions |
| 04/14/2004 | EP1407766A2 Pharmaceutical compositions that contain a salt of alendronic acid |
| 04/14/2004 | EP1407764A1 Implants for administering substances and methods of producing implants |
| 04/14/2004 | EP1407761A1 Stable hydroalcoholic compositions |
| 04/14/2004 | EP1407760A1 Method for protecting the skin from aging |
| 04/14/2004 | EP1407752A1 Composite powders and skin preparations for external use containing the same |
| 04/14/2004 | EP1407261A1 In vivo bioreactors |
| 04/14/2004 | EP1407047A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407032A1 Anti-neoplastic viral agents |
| 04/14/2004 | EP1407014A2 Screening method for attenuating or virulence defective microbial cells |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1406946A1 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 04/14/2004 | EP1406930A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 04/14/2004 | EP1406929A2 Glycoprotein vi fusion proteins |
| 04/14/2004 | EP1406916A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 04/14/2004 | EP1406915A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 04/14/2004 | EP1406914A2 Porphyrin derivatives for photodynamic therapy |
| 04/14/2004 | EP1406911A1 6-[2-(phosphonomethoxy)alkoxy]pyrimidine derivatives having antiviral activity |
| 04/14/2004 | EP1406910A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
| 04/14/2004 | EP1406907A1 New antitumoral derivatives of et-743 |
| 04/14/2004 | EP1406906A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 04/14/2004 | EP1406902A1 Hexahydroazepino(4,5-g)indoles and indolines as 5-ht receptor ligands |
| 04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
| 04/14/2004 | EP1406899A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 04/14/2004 | EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/14/2004 | EP1406897A2 Compounds |
| 04/14/2004 | EP1406895A1 Lactone formulations and method of use |
| 04/14/2004 | EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 04/14/2004 | EP1406893A1 Pyrrolidine bicyclic compounds |
| 04/14/2004 | EP1406892A1 Phenyl pyrazole derivatives as soluble epoxide hydrolase inhibitors |
| 04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 04/14/2004 | EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 04/14/2004 | EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
| 04/14/2004 | EP1406883A1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3) |
| 04/14/2004 | EP1406881A1 11-piperazinyldibenzo(b,f)(1,4)oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 04/14/2004 | EP1406880A1 Crystalline thiazine oxazolidinones |